However, this contrasts the more prevalent PTEN loss, which (in isolated IDC-P) is within the range observed in invasive prostate cancer without IDC-P, albeit significantly lower than in conventional IDC-P [19,46]. This evidence concerns the gene PTEN and prostate carcinoma.